Autoantibodies against p53 have been widely described in different types of cancer, such as CRC, BC, ovarian, or gastric cancers, among others, and their production has been mainly associated to missense mutations and p53 accumulation in cancer patients (49, 50). This evidence concerns the gene TP53 and colorectal carcinoma.